The global ovarian cancer drugs market is expected to grow from $1.49 billion in 2020 to $1.73 billion in 2021 at a compound annual growth rate (CAGR) of 16.1%. The growth is mainly due to the companies rearranging their operationssource https://www.openpr.com/news/2284078/2021-global-ovarian-cancer-drugs-market-size-and-forecast-key